KCM
TMO icon

Karp Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Karp Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,640
Closed -$1.34M – 97
2022
Q3 		$1.34M Sell
2,640
-99
-4% -$55.4K 0.27% 69
2022
Q2 		$1.49M Hold
2,739
– – 0.26% 85
2022
Q1 		$1.62M Sell
2,739
-456
-14% -$262K 0.24% 78
2021
Q4 		$2.13M Buy
3,195
+17
+0.5% +$10.6K 0.27% 82
2021
Q3 		$1.82M Hold
3,178
– – 0.26% 87
2021
Q2 		$1.6M Hold
3,178
– – 0.24% 89
2021
Q1 		$1.45M Sell
3,178
-1,057
-25% -$505K 0.26% 78
2020
Q4 		$1.97M Buy
4,235
+200
+5% +$93.8K 0.41% 69
2020
Q3 		$1.78M Buy
4,035
+30
+0.7% +$12.4K 0.44% 64
2020
Q2 		$1.45M Hold
4,005
– – 0.4% 58
2020
Q1 		$1.14M Sell
4,005
-975
-20% -$307K 0.37% 62
2019
Q4 		$1.62M Hold
4,980
– – 0.43% 67
2019
Q3 		$1.45M Buy
4,980
+35
+0.7% +$10K 0.42% 66
2019
Q2 		$1.45M Hold
4,945
– – 0.46% 68
2019
Q1 		$1.35M Sell
4,945
-800
-14% -$199K 0.48% 69
2018
Q4 		$1.29M Hold
5,745
– – 0.61% 55
2018
Q3 		$1.4M Sell
5,745
-460
-7% -$106K 0.48% 72
2018
Q2 		$1.28M Hold
6,205
– – 0.51% 66
2018
Q1 		$1.28M Sell
6,205
-130
-2% -$27.3K 0.52% 64
2017
Q4 		$1.2M Buy
6,335
+210
+3% +$40.2K 0.51% 63
2017
Q3 		$1.16M Sell
6,125
-2,946
-32% -$534K 0.54% 59
2017
Q2 		$1.58M Buy
+9,071
New +$1.52M 0.78% 50
2015
Q4 		– Sell
-1,150
Closed -$141K – 268
2015
Q3 		$141K Buy
1,150
+300
+35% +$39.1K 0.1% 106
2015
Q2 		$110K Sell
850
-150
-15% -$19.6K 0.07% 121
2015
Q1 		$134K Buy
1,000
+475
+90% +$61.2K 0.09% 117
2014
Q4 		$66K Buy
+525
New +$63.8K 0.05% 150

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Karp Capital Management's TMO Position: Q4 2022 in Review

Karp Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2022, closing a stake of 2,640 shares — an estimated $1.34M sold.

Karp Capital Management first reported a position in TMO in Q4 2014 and held it in 26 quarters. The position peaked at $2.13M in Q4 2021. 2,374 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

  • Karp Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2022 after selling out during the quarter.
  • Karp Capital Management sold 2,640 Thermo Fisher Scientific shares in Q4 2022, an estimated $1.34M.
  • Karp Capital Management first reported a position in Thermo Fisher Scientific in Q4 2014 and held it in 26 quarters.
  • Karp Capital Management's Thermo Fisher Scientific position peaked at $2.13M in Q4 2021.
  • 2,374 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Karp Capital Management's 13F filing for Q4 2022.